By
Proposed state policies intended to control the opioid abuse epidemic
over the past decade have faced a $3.7 million roadblock — the amount
of money spent by drug companies and related advocacy groups to
influence New York lawmakers.
A joint investigation by The
Associated Press and the Center for Public Integrity found members of
the Pain Care Forum, composed of drugmakers and allied advocacy groups,
spent more than $880 million on campaign contributions and lobbying over
the past decade as they worked to influence state and federal policies.
The groups have an array of political interests that include opioid
advocacy, and their spending was eight times that of the gun lobby
during the same period. By comparison, groups advocating for limits on
opioid prescribing spent about $4 million.
Click here for the full article.
Source: pressconnects.com (via The Empire Report)
No comments:
Post a Comment